Akt phosphorylation and arrhythmogenic modification of the cardiac sodium channel
Akt phosphorylation and arrhythmogenic modification of the cardiac sodium channel
批准号:
18590757
负责人:
MAKITA Naomasa
金额:
$2.53万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
Akt是一种丝氨酸-苏氨酸磷酸酶,参与多种信号转导,包括细胞增殖和凋亡。Akt在小鼠心脏中的选择性过表达导致心脏肥大,但偶尔,一些转基因小鼠在心脏肥大完全建立之前突然死亡,原因不明,这表明Akt诱导期间存在危及生命的心律失常。本研究的目的是阐明Akt诱导的心肌肥大和致死性心律失常的生物物理和生化机制。我们专注于心脏Na通道Navl.5,因为Navl.5与其他心脏离子通道不同,具有两个Akt磷酸化识别序列(RXRXXT/S)。将Navl.5与Akt或其磷酸化缺陷突变体Akt-3A(K179 A + T308 A + S478 A)一起在HEK 293细胞中共表达,并通过全细胞膜片钳技术测定生物物理特性。Akt显著增加了Nav.15的电流密度,但Akt-3A没有增加。电压依赖性的激活曲线,但不是失活,显着转移的去极化方向。此外,FLAG标记的Nav.15与抗磷酸化Akt抗体的共免疫沉淀显示Akt而不是Akt-3A增加了Akt与心脏Na通道的结合。这些结果表明Akt改变了Na通道的生物物理特性和表达水平,导致致死性心律失常的发生。需要进一步研究包括在Aid转基因小鼠体内记录ECG来阐明心脏Akt信号通路与致死性心律失常之间的机制联系。
英文摘要
Akt is a serine-threonine phosphatase implicated in wide variety of signal transductions including cell proliferation and apoptosis. Selective overexpression of Akt in mice heart results in cardiac hypertrophy, but occasionally, some transgenic mice die suddenly with unknown causes before the cardiac hypertrophy is fully established, suggesting life-threatening arrhythmias during Akt-induction. The purpose of the study was to elucidate the biophysical and biochemical mechanisms underlying Akt-induced cardiac hypertrophy and lethal arrhythmias. We focused on cardiac Na channel Navl.5, because Navl.5, unlike other cardiac ion channels, has two Akt phosphorylation recognition sequences (RXRXXT/S). Navl.5 was coexpressed in HEK 293 cells together with Akt or its phosphorylation deficient mutant Akt-3A (K179A+T308A+S478A), and the biophysical properties were determined by whole-cell patch clamp technique. Current density of Nav.15 was significantly increased by Akt but not by Akt-3A. Voltage-dependence of the activation curve, but not inactivation, was significantly shifted in the depolarizing direction. Furthermore, coimmunoprecipitation of FLAG-tagged Nav.15 with anti-phosphorylated-Akt antibodies revealed that Akt but not Akt-3A increased the association of Akt with cardiac Na channel. These results suggest that Akt modified the biophysical properties and expression levels of Na channel, leading to induce of lethal arrhythmias. Further study including in vivo ECG recording in Aid transgenic mice are required to elucidate the mechanistic link between cardiac Akt signaling pathway and the lethal arrhythmias.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
心筋Naチャネル病
心脏钠离子通道疾病
DOI:
--
发表时间:
2006
期刊:
医学の歩み 217
影响因子:
--
作者:
[蒔田直昌, ら]
通讯作者:
ら
Left Ventricular Noncompaction Associated With Mutations in Cardiac Na Channel Gene SCN5A
左心室致密化不全与心脏 Na 通道基因 SCN5A 突变相关
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[Makita N. , et. al., 蒔田直昌, 蒔田直昌, 蒔田直昌, Makita N, Makita N]
通讯作者:
Makita N
DOI:
10.1253/circj.72.1018
发表时间:
2008-06-01
期刊:
CIRCULATION JOURNAL
影响因子:
3.3
作者:
[Makita, Naomasa, Mochizuki, Naoki, Tsutsui, Hiroyuki]
通讯作者:
Tsutsui, Hiroyuki
DOI:
10.1172/jci30651
发表时间:
2007-07-01
期刊:
JOURNAL OF CLINICAL INVESTIGATION
影响因子:
15.9
作者:
[Nakaoka, Yoshikazu, Nishida, Keigo, Mochizuki, Naoki]
通讯作者:
Mochizuki, Naoki
Genetic polymorphisms and arrhythmia susceptibility
遗传多态性与心律失常易感性
DOI:
--
发表时间:
2007
期刊:
Circ J 71
影响因子:
--
作者:
[Makita N , et. al.]
通讯作者:
et. al.
共 24 条
Novel molecular basis underlying lethal arrhythmic syndrome due to mutations in cardiac Na/Ca exchanger gene
-
批准号:18H02808
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.15万
-
财政年份:2018
-
负责人:MAKITA Naomasa
-
依托单位:
Novel molecular basis of cardriac conduction disturbance associated with a collagene gene mutation
-
批准号:15K15311
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2015
-
负责人:MAKITA Naomasa
-
依托单位:
Elucidation of novel pathophysiology underlysing lethal arrhythmia due to mutations in cardiac ion transporters
-
批准号:15H04823
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.4万
-
财政年份:2015
-
负责人:MAKITA Naomasa
-
依托单位:
Identification of Novel Genes and Pathogenesis Responsible for Brugada Syndrome Using Whole Exome Sequencing
-
批准号:24390199
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.48万
-
财政年份:2012
-
负责人:MAKITA Naomasa
-
依托单位:
Mutations in cardiac gap junction genes and the pathophysiology underlying progressive cardiac conduction defect.
-
批准号:21590921
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:MAKITA Naomasa
-
依托单位:
Phamacogenomic studies for the genetic basis for lethal arrhythmias
-
批准号:15590711
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2003
-
负责人:MAKITA Naomasa
-
依托单位:
国内基金
海外基金
登录
查看更多内容
SENP5调控磷酸化STAT2的SUMO修饰促进抗病毒天然免疫的机制研
究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:胡源
-
依托单位:
酪氨酸磷酸酶SHP1新型作用底物THEMIS的鉴定及其在免疫T细胞发育过程中的功能探究
-
批准号:32070776
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:范高峰
-
依托单位:
MG53蛋白的翻译后修饰调节及其应用研究
-
批准号:31970722
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:吕凤祥
-
依托单位:
ALDH6A1缺损重塑糖脂代谢促进肝细胞癌发生的机制研究
-
批准号:91957109
-
项目类别:重大研究计划
-
资助金额:79.0万元
-
批准年份:2019
-
负责人:黄赞
-
依托单位:
β-Catenin 蛋白Tyr142位点磷酸化修饰促进肝癌发生的机制研究
-
批准号:31970724
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:邵永平
-
依托单位:
FgAtm1-FgHapX途径调控禾谷镰刀菌铁平衡的机制研究
-
批准号:31871910
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:尹燕妮
-
依托单位:
磷酸化和可变剪切修饰影响Bnip3调控线粒体自噬和细胞凋亡的结构及功能研究
-
批准号:31670742
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2016
-
负责人:张星亮
-
依托单位:
Tip60的磷酸化调控及功能
-
批准号:31000621
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:林舒勇
-
依托单位:
RNA干扰沉默糖原合成激酶3β对tau蛋白磷酸化的作用研究
-
批准号:30970989
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2009
-
负责人:边红
-
依托单位:
白质消融性白质脑病中胶质细胞选择性受累的机制研究
-
批准号:30872793
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2008
-
负责人:吴晔
-
依托单位: